Study to Assess PK, Safety and Tolerability in Patients With DM and CKD
NCT03795389
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
33
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Kidney Disease
Chronic Kidney Disease, Stage 3 (Moderate)
Chronic Kidney Disease, Stage 4 (Severe)
Diabetes
Interventions
DRUG:
DM199
Sponsor
DiaMedica Therapeutics Inc